Your search returned 33 studies. (Get alerts for new studies):
- Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Melanoma (Skin)
2 Locations available
- Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Lapatinib in Stage IV Melanoma With ERBB4 Mutations
Conditions: Malignant Melanoma
3 Locations available
- Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
Conditions: Metastatic Malignant Uveal Melanoma
4 Locations available
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
220 Locations available
- Panobinostat (LBH589) in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
1 Location available
- Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Conditions: Malignant Melanoma
2 Locations available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Conditions: Melanoma
3 Locations available
- Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma - Metastatic Kidney Cancer
2 Locations available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Conditions: Esophageal Cancer - Bile Duct Neoplasms - Gastric Cancer - Liver Cancer - Melanoma - Pancreatic Cancer - Sarcoma
1 Location available
- SciBase International Melanoma Pivotal Study
Conditions: Malignant Melanoma
1 Location available
- High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Conditions: Malignant Melanoma
1 Location available
- Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
16 Locations available
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Malignant Melanoma
2 Locations available
- A Study of RO5185426 And GDC-0973 in Patients With BRAF-Mutation Positive Metastatic Melanoma
Conditions: Malignant Melanoma
6 Locations available
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Conditions: Breast Cancer - Genitourinary Cancer - Malignant Female Reproductive System Neoplasm - Melanoma - Sarcoma
1 Location available
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
Conditions: Tumors - Malignant Melanoma - Hematological Malignancies - Myelogenous Leukemia, Chronic - Leukemia, Lymphoblastic, Acute
1 Location available
- Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Conditions: Malignant Melanoma, Metastatic
1 Location available
- Trial of pIL-12 Electroporation Malignant Melanoma
Conditions: Melanoma
3 Locations available
- Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutatio
Conditions: Malignant Melanoma
2 Locations available
- A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients Wi
Conditions: Malignant Melanoma
2 Locations available
- IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
Conditions: Malignant Melanoma
1 Location available
- A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Conditions: Malignant Melanoma
1 Location available
- Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Conditions: Colon Cancer - Head and Neck Cancer - Lung Cancer - Lymphoma - Malignant Neoplasm - Melanoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma
Conditions: Melanoma
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Conditions: Malignant Melanoma
3 Locations available
- A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Conditions: Malignant Melanoma
8 Locations available
|